These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26602314)

  • 21. Lymphocyte transformation test for the evaluation of adverse effects of antituberculous drugs.
    Schreiber J; Zissel G; Greinert U; Schlaak M; Müller-Quernheim J
    Eur J Med Res; 1999 Feb; 4(2):67-71. PubMed ID: 10066642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gynaecomastia during antituberculosis chemotherapy with isoniazid.
    Dixit R; Sharma S; Nawal CL
    J Assoc Physicians India; 2008 May; 56():390-1. PubMed ID: 18700651
    [No Abstract]   [Full Text] [Related]  

  • 23. [Fixed drug eruption after taking ethambutol].
    Bakayoko AS; Kaloga M; Kamagate M; Kone Z; Daix AT; Ohui E; Gbery I; Domoua K
    Rev Mal Respir; 2015 Jan; 32(1):48-51. PubMed ID: 25618204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rifampicin-induced lichenoid drug eruption.
    Bhanja DB; Sil A; Panigrahi A; Chakraborty S
    Postgrad Med J; 2020 Dec; 96(1142):782-783. PubMed ID: 32015190
    [No Abstract]   [Full Text] [Related]  

  • 25. Lichenoid drug reaction to isoniazid presenting as exfoliative dermatitis in a patient with acquired immunodeficiency syndrome.
    Thakur BK; Verma S; Mishra J
    Int J STD AIDS; 2015 Jun; 26(7):512-5. PubMed ID: 25013221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Apoptosis-inducing action of antituberculosis drugs of the main group in vitro].
    Vasilyeva OA; Serebryakova VA; Urazova OI; Novitsky VV; Kononova TE; Naslednikova IO
    Antibiot Khimioter; 2010; 55(11-12):25-9. PubMed ID: 21574422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-induced heart failure in advanced pulmonary tuberculosis.
    Daynes G
    S Afr Med J; 1974 Nov; 48(57):2352-3. PubMed ID: 4432186
    [No Abstract]   [Full Text] [Related]  

  • 28. Enhancement of treatment completion for latent tuberculosis infection with 4 months of rifampin.
    Lardizabal A; Passannante M; Kojakali F; Hayden C; Reichman LB
    Chest; 2006 Dec; 130(6):1712-7. PubMed ID: 17166986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Four cases of similar Hexheimer's reaction during the initial chemotherapy for tuberculosis bacillus].
    Lu H; Wu H; Liang G
    Zhonghua Jie He He Hu Xi Za Zhi; 1995 Dec; 18(6):348-50, 382-3. PubMed ID: 8762493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Eruption after the 1st dose of standard antitubercular chemotherapy. Thoughts on pyrazinamide].
    Radal M; Jonville-Bera AP; Van-Egroo C; Carré P; Lemarié E; Autret E
    Rev Mal Respir; 1998 Jun; 15(3):305-6. PubMed ID: 9677642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
    Zierski M; Bek E
    Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
    [No Abstract]   [Full Text] [Related]  

  • 32. [Stevens-Johnson syndrome and toxic epidermal necrolysis after intake of rifampicin-isoniazid: report of 8 cases in HIV-infected patients in Togo].
    Pitche P; Mouzou T; Padonou C; Tchangai-Walla K
    Med Trop (Mars); 2005 Sep; 65(4):359-62. PubMed ID: 16548490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antitubercular drug-induced liver injuries].
    Guo Y; Cui D
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):308-9. PubMed ID: 11326960
    [No Abstract]   [Full Text] [Related]  

  • 34. Isoniazid and rifampicin rarely cause acute pancreatitis in patients with tuberculosis.
    Chan TY
    Int J Clin Pharmacol Ther; 1999 Feb; 37(2):109. PubMed ID: 10082175
    [No Abstract]   [Full Text] [Related]  

  • 35. [Serious bullous cutaneous lesions induced by isoniazid].
    Trabelsi S; El Aïdli S; Amrani R; Ourari B; Klouz A; Lakhal M; Loueslati MH; Daghfous R; Beji M; Belkahia C
    Therapie; 2005; 60(6):599-600. PubMed ID: 16555503
    [No Abstract]   [Full Text] [Related]  

  • 36. Successful treatment of isoniazid-induced lichenoid drug eruption with acitretin.
    Chen C; Nguyen GH; Zeng YP; Wang BX
    Eur J Dermatol; 2018 Feb; 28(1):82-83. PubMed ID: 29171404
    [No Abstract]   [Full Text] [Related]  

  • 37. Safety of 3 different reintroduction regimens of antituberculosis drugs after development of antituberculosis treatment-induced hepatotoxicity.
    Sharma SK; Singla R; Sarda P; Mohan A; Makharia G; Jayaswal A; Sreenivas V; Singh S
    Clin Infect Dis; 2010 Mar; 50(6):833-9. PubMed ID: 20156055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective evaluation of antituberculosis therapy in patients with human immunodeficiency virus infection.
    Jones BE; Otaya M; Antoniskis D; Sian S; Wang F; Mercado A; Davidson PT; Barnes PF
    Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 1):1499-502. PubMed ID: 7952606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemotherapy of tuberculosis.
    Pinsker KL; Koerner SK
    Am J Hosp Pharm; 1976 Mar; 33(3):275-83. PubMed ID: 769544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Light and electron microscopy studies of the liver in tuberculosis patients receiving rifampin and isoniazid].
    Pilheu JA; de Salvo MC; Koch O; Barcat JA
    Medicina (B Aires); 1981; 41(4):439-45. PubMed ID: 7339434
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.